|
Evaxion A/S
(NASDAQ: EVAX)
|
9:00 PM UTC, 12/12/25 | |||
|---|---|---|---|---|
| Last: $6.21 | Change: -0.24 | %Change: -3.72% | Volume: 70,895 | |
11:09 AM EST, 02/12/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts were treading water late Wednesday morning, edging 0.03% lower to 1,397.50 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by pharmaceutical company Ascendis Pharma (ASND) and furniture maker Natuzzi (NTZ), which rose 3.4% and 2.5%, respectively. They were followed by brewing company Anheuser-Busch InBev (BUD) and financial services company Banco Santander (SAN), which were up 2% and 1.8%, respectively.
The decliners from continental Europe were led by accommodations booking company trivago (TRVG) and biotech firm Evaxion Biotech (EVAX), which fell 8.9% and 4.3% respectively. They were followed by semiconductor company Sequans Communications (SQNS) and petroleum refiner Equinor (EQNR), which dropped 4.2% and 3% respectively.
From the UK and Ireland, the gainers were led by insurance company Prudential (PUK) and biopharmaceutical company Verona Pharma (VRNA), which advanced 6.6% and 4.6% respectively. They were followed by biopharmaceutical companies Bicycle Therapeutics (BCYC) and Amarin (AMRN), which increased 2.7% and 2.3% respectively.
The decliners from the UK and Ireland were led by biopharmaceutical companies NuCana (NCNA) and Biodexa Pharmaceuticals (BDRX), which lost 2.7% and 2.6% respectively. They were followed by utilities company National Grid (NGG) and communications company WPP (WPP), which were down 2% each.
http://www.mtnewswires.com
Copyright © 2025 MT Newswires. All rights reserved. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.